Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond Therapeutics, Inc.

2.31
-0.1200-4.94%
Post-market: 2.30-0.0100-0.43%17:36 EDT
Volume:563.47K
Turnover:1.31M
Market Cap:131.35M
PE:26.22
High:2.38
Open:2.34
Low:2.30
Close:2.43
Loading ...

Black Diamond Therapeutics Inc. Conducted Virtual Annual Meeting

Reuters
·
Yesterday

Black Diamond Therapeutics Inc. to Participate in Jefferies Global Healthcare Conference

Reuters
·
29 May

Black Diamond Therapeutics reports Q1 diluted EPS 98c vs. (35c) last year

TIPRANKS
·
13 May

Black Diamond Therapeutic Q1 EPS $0.98 Beats $0.02 Estimate, Sales $70.00M

Benzinga
·
13 May

Black Diamond Therapeutics Reports Q1 2025 Results: Net Income Surges to $56.5M, R&D Expenses Decrease

Reuters
·
13 May

Black Diamond Therapeutics- Cash, Cash Equivalents, $152.4 Mln as of March 31, 2025; Expected to Be Sufficient to Fund Operations Into Q4 of 2027

THOMSON REUTERS
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 May

Black Diamond Therapeutics Inc expected to post earnings of 20 cents a share - Earnings Preview

Reuters
·
05 May

Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year

Simply Wall St.
·
04 May

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
31 Mar

3 Penny Stocks to Watch Now, 3/20/25

TIPRANKS
·
20 Mar

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires Live
·
20 Mar

Top Midday Gainers

MT Newswires
·
20 Mar

Black Diamond Therapeutics Shares up 36% on Licensing Deal for Tumor Treatment

THOMSON REUTERS
·
19 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Aterian, Autodesk, Ollie's

Reuters
·
19 Mar

Black Diamond Therapeutics Shares up 32.7% Premarket on Licensing Deal for Tumor Treatment

THOMSON REUTERS
·
19 Mar

BUZZ-Black Diamond rises on licensing deal for tumor treatment

Reuters
·
19 Mar

Black Diamond, Servier announce global licensing agreement for BDTX-4933

TIPRANKS
·
19 Mar

BRIEF-Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy

Reuters
·
19 Mar

Black Diamond Therapeutics - to Receive $70 Million Upfront, up to $710 Million in Milestones

THOMSON REUTERS
·
19 Mar